A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs (Q1193125)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs |
scientific article; zbMATH DE number 62006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs |
scientific article; zbMATH DE number 62006 |
Statements
A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs (English)
0 references
27 September 1992
0 references
cell-cycle-phase-specific drugs
0 references
AIDS drugs
0 references
zidovudine
0 references
AZT
0 references
cancer drugs
0 references
cytosine arabinoside
0 references
ara-C
0 references
duration of the dosing interval
0 references
life-cycle parameters
0 references
drug-susceptible life phase
0 references
proliferation rate
0 references
drug toxicity
0 references
average cycle time of the host susceptible cells
0 references
0 references
0.8676609
0 references
0.8513997
0 references
0.8419807
0 references
0.8290471
0 references
0.8269157
0 references
0.82663095
0 references
